---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-000589"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2026-01-28T23:59:59+00:00"
generated_at: "2026-05-16T06:55:08.177405+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals appoints Vanessa Jacoby to board; Birnbaum retires as director

## Summary
- Dr. Jay Birnbaum retired from board Jan 28, 2026; will serve as consultant for one year, receiving 5,000 RSUs per quarter.
- Vanessa Jacoby appointed director effective Jan 28, replaces Birnbaum as independent director; will chair Audit Committee.
- Jacoby receives initial grant of options to purchase 10,000 shares vesting over 3 years; annual retainer $32,500 plus committee fees.
- Board amended director compensation plan to allow discretion in annual option grant size and form of initial equity grants.

## SEC filing metadata
- accession: 0001683168-26-000589
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2026-01-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316826000589/0001683168-26-000589-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316826000589/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-000589
- JSON: https://secwatch.observer/filing/0001683168-26-000589.json
- Plain text: https://secwatch.observer/filing/0001683168-26-000589.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.